CSIMarket
 


Dicerna Pharmaceuticals Inc   (DRNA)
Other Ticker:  
 


Dicerna Pharmaceuticals Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



DRNA Gross Profit Margin (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Revenue Change 28.81 % 2.2 % 39.89 % 478.47 % 508.28 %
Seq. Revenue Change 52.29 % -13.16 % 16.23 % -16.2 % 20.83 %
Revenue In Millions $62.95 $41.34 $47.60 $40.96 $48.88
Gross Profit Margin - - - - -
Gross Profit Margin Total Ranking # 801 # 61 # 725 # 780 # 705
Gross Profit In Millions $62.95 $41.34 $47.60 $40.96 $48.88
Y / Y Gross Profit Change - - - - -
Seq. Gross Profit Change - - - - -


Commenting Third Quarter 2021 Gross Profit Margin
Dicerna Pharmaceuticals Inc has managed to improve its Revenue sequentially to $63 millions by 52.29 % faster than Gross Profit increase of 52.29 % to $63 millions, this led to contraction in Gross Profit Margin to 100 %, a new company low.

Observing third quarter 2021 results within Major Pharmaceutical Preparations industry 142 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated compare to previous quarter from 61 to 801.
Learn about Gross Margin
DRNA's Gross Profit Margin third quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 143
Healthcare Sector # 236
Overall # 791

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Sep 30 2021)  




Other Gross Profit Margin Profitability Ratios
DRNA's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
DRNA's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for DRNA's Competitors
Gross Profit Margin Profit Margin for Dicerna Pharmaceuticals Inc 's Suppliers
Gross Profit Margin Profit Margin for DRNA's Customers

You may also want to know
DRNA's Annual Growth Rates DRNA's Profitability Ratios DRNA's Asset Turnover Ratio DRNA's Dividend Growth
DRNA's Roe DRNA's Valuation Ratios DRNA's Financial Strength Ratios DRNA's Gross Profit Growth
DRNA's Roa DRNA's Inventory Turnover Ratio DRNA's Growth Rates DRNA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2021, within Major Pharmaceutical Preparations Industry Gross Profit MarginSep 30 2021 MRQ Gross ProfitSep 30 2021 MRQ Revenue
Abcellera Biologics Inc   100.00 %$ 5.508 $ 5.508 
Arbutus Biopharma Corp  100.00 %$ 3.340 $ 3.340 
Adicet Bio Inc   100.00 %$ 3.429 $ 3.429 
Acura Pharmaceuticals inc  100.00 %$ 0.270 $ 0.270 
Alpine Immune Sciences Inc   100.00 %$ 8.516 $ 8.516 
Altimmune Inc   100.00 %$ 0.170 $ 0.170 
Anaptysbio Inc   100.00 %$ 20.890 $ 20.890 
Apellis Pharmaceuticals Inc   100.00 %$ 5.650 $ 5.650 
Aptevo Therapeutics Inc   100.00 %$ 3.096 $ 3.096 
Aravive Inc   100.00 %$ 2.412 $ 2.412 
Arcturus Therapeutics Holdings Inc   100.00 %$ 2.437 $ 2.437 
Aridis Pharmaceuticals Inc   100.00 %$ 0.515 $ 0.515 
Ardelyx Inc   100.00 %$ 1.173 $ 1.173 
Arvinas Inc   100.00 %$ 9.285 $ 9.285 
Arrowhead Pharmaceuticals Inc   100.00 %$ 38.282 $ 38.282 
Assembly Biosciences Inc   100.00 %$ 6.254 $ 6.254 
Atai Life Sciences N v   100.00 %$ 0.266 $ 0.266 
Athersys Inc  100.00 %$ 4.792 $ 4.792 
Actinium Pharmaceuticals Inc   100.00 %$ 0.233 $ 0.233 
Atea Pharmaceuticals Inc   100.00 %$ 32.811 $ 32.811 
Axim Biotechnologies Inc   100.00 %$ 0.008 $ 0.008 
Bicycle Therapeutics Plc  100.00 %$ 4.333 $ 4.333 
Biora Therapeutics Inc   100.00 %$ 0.182 $ 0.182 
Bellicum Pharmaceuticals Inc   100.00 %$ 5.006 $ 5.006 
Bolt Biotherapeutics Inc   100.00 %$ 0.752 $ 0.752 
Barinthus Biotherapeutics Plc  100.00 %$ 0.019 $ 0.019 
Calithera Biosciences Inc   100.00 %$ 6.750 $ 6.750 
Cara Therapeutics inc   100.00 %$ 20.272 $ 20.272 
Catalyst Biosciences Inc   100.00 %$ 2.299 $ 2.299 
Chemocentryx Inc.  100.00 %$ 35.486 $ 35.486 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com